Skip to main content
Clinical Trials/NCT01854515
NCT01854515
Unknown
Not Applicable

Comparison of Efficacy of Nebulizing Budesonide and Intravenous Dexamethasone Before Extubation on Prevention of Post-extubation Complications in Intensive Care Unit Patients

Saeed Abbasi1 site in 1 country90 target enrollmentMarch 2012

Overview

Phase
Not Applicable
Intervention
Budesonide
Conditions
Respiratory Sounds
Sponsor
Saeed Abbasi
Enrollment
90
Locations
1
Primary Endpoint
post extubation stridor
Last Updated
12 years ago

Overview

Brief Summary

The present study was aimed at investigating the efficacy of nebulizing Budesonide sin comparison with intravenous Dexamethasone before extubation in prevention of post-extubation complications amongst patients admitted in intensive care unit.

In this double-blind randomized clinical trial study, 90 patients (age between 18 to 65) who are intubated (at least for 48 hours) and now are ready for extubation will be enrolled in the study after obtaining a written informed consent from their parents or guardians.

The investigators divide our patients randomly into two equal groups.

-In the budesonide group patients underwent a therapy with nebulizing Budesonide at a dose of 1 mg diluted in 4 cc of sterile water for 20 minutes, one hour preceding extubation. After extubation patients received nebulizing budesonide via oxygen mask at the same dose every 12 hours for 48 h.i In dexamethasone group intravenous dexamethasone was administered to patient at a dose of 0.15 mg/kg before extubation. After extubation, the administration of intravenous Dexamethasone continued at the same dose every 12 h. for 48 h.

Another anesthesiologist who is unaware about kind of medication, will evaluate the patients for severity of stridor. We will record the vital sings and grade of stridor every 6 hour. Respiratory rate (RR), heart rate (HR), blood pressure (BP) and oxygen saturation (SPO2) were recorded for each patient immediately before aerosol administration (time 0) and at 30 and 60 min; and 2,4,8,12,24,36 and 48 hrs. After extubation then the presence of stridor (heard with the aid of stethoscope) was recorded within 48 hr of extubation

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
September 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Saeed Abbasi
Responsible Party
Sponsor Investigator
Principal Investigator

Saeed Abbasi

Assistant Professor in Anesthesiology

Isfahan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients' age 18-65 years old
  • Intubated for more than 48 hours after surgery
  • Met the weaning criteria defined as respiratory rate \< 30 breaths / min, negative tidal volume \> 5 ml/kg ideal body weight, and shallow index (respiratory rate/tidal volume) \< 105 breaths / min/L

Exclusion Criteria

  • Any history of corticosteroid therapy in previous week
  • Nasal or throat disease / surgery
  • Pulmonary airway disease
  • Gastrointestinal bleeding

Arms & Interventions

Budesonide

1 mg diluted in 4 cc of sterile water for 20 minutes, one hour preceding extubation. After extubation patients received nebulizing Budesonide via oxygen mask at the same dose every 12 h. for 48 h.

Intervention: Budesonide

Dexamethasone

0.15 mg/kg before extubation. After extubation, the administration of intravenous Dexamethasone continued at the same dose every 12 h. for 48 h.

Intervention: Dexamethasone acetate

Outcomes

Primary Outcomes

post extubation stridor

Time Frame: After extubation until 48 hours

Until 48 hours after extubation we documented if there is stridor in examination

Study Sites (1)

Loading locations...

Similar Trials